» Articles » PMID: 25796037

Increased Testosterone Levels and Cortisol Awakening Responses in Patients with Borderline Personality Disorder: Gender and Trait Aggressiveness Matter

Overview
Date 2015 Mar 22
PMID 25796037
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Borderline personality disorder (BPD) is characterized by antagonism, negative affectivity, disinhibition, and impairments in interpersonal functioning, including enhanced impulsive aggression. Interpersonal dysfunctions may be related to alterations in endocrine systems. The current study investigated alterations in basal activity of the hypothalamus-pituitary-gonadal (HPG) reproductive and the hypothalamus-pituitary-adrenal (HPA) stress system in BPD patients and their association to anger-related aggression with a particular focus on effects of gender and comorbid conditions of depression and posttraumatic stress disorder (PTSD).

Method: Saliva testosterone levels as well as cortisol awakening responses were assessed in 55 medication-free female and male patients with BPD and compared to 47 gender-, age-, and intelligence-matched healthy volunteers. In addition, analyses controlling for current depression and PSTD and bivariate correlations between testosterone and cortisol levels on the one hand and anger and aggressiveness on the other hand were performed.

Results: The results revealed increased saliva testosterone levels in female and male patients with BPD as well as elevated cortisol awakening responses in female, but not male patients with BPD compared to healthy volunteers. Cortisol awakening responses were positively related to anger and aggressiveness in female patients with BPD, but no associations were found with testosterone levels.

Conclusion: In line with previous reports, the present results suggest endocrine alterations in BPD which may be associated with interpersonal impairments, such as increased anger-related aggressive behavior and could have implications for the development of new (psychopharmaco-) therapeutic interventions that may help to restore the alterations in the HPA and HPG systems.

Citing Articles

The assessment of the sexuality of patients with a borderline personality disorders based on their 2D:4D digit ratio.

Holka-Pokorska J, Kucharski A Sex Med. 2025; 13(1):qfaf006.

PMID: 39958520 PMC: 11828702. DOI: 10.1093/sexmed/qfaf006.


The impact of ovulation-suppressing contraceptives on behavioral and functional difficulties in borderline personality disorder.

Katrinli S, Rothbaum A, DeMoss R, Turner W, Hunter B, Powers A Neuropsychopharmacology. 2025; .

PMID: 39799250 DOI: 10.1038/s41386-024-02045-4.


Salivary testosterone is associated with feelings of senselessness and self-dislike in women with borderline personality disorder.

Kulakova E, Graumann L, Cho A, Deuter C, Wolf O, Hellmann-Regen J Eur J Psychotraumatol. 2024; 15(1):2431368.

PMID: 39621360 PMC: 11613350. DOI: 10.1080/20008066.2024.2431368.


Blunted Cortisol Awakening Response Is Associated with External Attribution Bias Among Individuals with Personality Disorders.

Bogudzinska B, Maciaszek J, Stanczykiewicz B, Bielawski T, Dybek A, Alejnikowa J Brain Sci. 2024; 14(10).

PMID: 39452052 PMC: 11505697. DOI: 10.3390/brainsci14101040.


The Impact of Estrogen-Suppressing Contraceptives on Behavioral and Functional Difficulties in Borderline Personality Disorder.

Katrinli S, Rothbaum A, DeMoss R, Turner W, Hunter B, Powers A medRxiv. 2024; .

PMID: 39281740 PMC: 11398603. DOI: 10.1101/2024.09.04.24313069.